ELF Test™

CE sertifikalı ilk Karaciğer Fibrozu Marker Paneli
ELF Test

The ELF™ Test* is a simple, accurate, minimally-invasive blood test for measuring liver damage (known as fibrosis). It offers a quick straightforward method of providing valuable information:

  • Minimal or no patient discomfort
  • Identifies significant liver disease

Because ELF uses a blood sample rather than a biopsy, it can be used routinely for the same patient over time.

The ELF test combines three serum biomarkers which have been shown to correlate to the level of liver fibrosis assessed by liver biopsy. These biomarkers include:

  • Hyaluronic acid (HA)
  • Procollagen III amino terminal peptide (PIIINP)
  • Tissue inhibitor of metalloproteinase 1 (TIMP-1)

The algorithm measures each of these markers by immunoassay, to create an ELF score. Sampling for the ELF test can be performed in a physician’s office or health center.

Download ELF specification sheet

What is liver fibrosis?

Non-invasive markers of liver fibrosis

The ELF Program

*Not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.

"The discovery of the ELF markers represents a significant advance in the diagnosis of patients with liver disease. Of particular benefit, the ELF test can help diagnose patients with mild-to-moderate liver fibrosis, which is usually asymptomatic, so that clinicians are able to intervene before significant damage to the liver occurs."

William Rosenberg, MD
Centre for Hepatology
University College London